Medtronic PLC plans to pay $54.5m to settle a class-action suit brought by investors into cardiac device company HeartWare International Inc., which Medtronic had acquired in 2016. The plaintiffs say HeartWare mislead them about the safety and regulatory future of a miniaturized ventricular-assist device (MVAD).
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?